Consultation on guidance on personal production of cannabis for medical purposes

From Health Canada

Health Canada invited Canadians to share their perspectives on the factors that may be considered for refusal or revocation of a registration on public health and public safety grounds. These factors were set out in the draft guidance on personal production of cannabis for medical purposes.

Who was the focus of this consultation

Health Canada engaged with various groups across Canada including:

• All interested Canadians, including Indigenous Peoples
• Patients and patient associations
• Provincial, territorial, and local governments
• Cannabis industry licence holders and associations
• Law enforcement and first responders and associations
• Health care practitioners and health care practitioner regulatory bodies and associations

Comments from any group or Canadian who was interested in participating were welcome.

Key questions for discussion

The draft document provided guidance on the personal and designated production of cannabis for medical purposes. It also proposed factors that may be considered in refusing or revoking a registration. The following questions were asked:

• Are the listed factors clear?
• Are there any additional factors that should also be considered?
• Do you have any comments on other elements of this document unrelated to the factors for consideration?

The input that was gathered through this consultation will be considered before publishing the final guidance document. Health Canada will publish a "What we heard" report and the final version of the guidance document.

Contact us

Controlled Substances and Cannabis Branch
Health Canada
Address locator 0302B
Ottawa, Ontario
K1A 0K9

Email: cannabis@canada.ca